Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Payables (2016 - 2021)

Phio Pharmaceuticals' Payables history spans 10 years, with the latest figure at $322000.0 for Q3 2021.

  • For Q3 2021, Payables fell 56.6% year-over-year to $322000.0; the TTM value through Sep 2021 reached $322000.0, down 56.6%, while the annual FY2020 figure was $728000.0, 10.01% down from the prior year.
  • Payables reached $322000.0 in Q3 2021 per PHIO's latest filing, down from $348000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $856000.0 in Q3 2019 to a low of $322000.0 in Q3 2021.
  • Average Payables over 5 years is $619631.6, with a median of $672000.0 recorded in 2017.
  • Peak YoY movement for Payables: surged 149.49% in 2017, then plummeted 56.6% in 2021.
  • A 5-year view of Payables shows it stood at $511000.0 in 2017, then increased by 7.63% to $550000.0 in 2018, then surged by 47.09% to $809000.0 in 2019, then decreased by 10.01% to $728000.0 in 2020, then plummeted by 55.77% to $322000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Payables are $322000.0 (Q3 2021), $348000.0 (Q2 2021), and $615000.0 (Q1 2021).